June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Psoriatic uveitis : a potentially severe and sight-threatening entity?
Author Affiliations & Notes
  • Céline Mebsout
    Ophtalmologie, Hôpital La Pitié Salpétrière Paris, Paris, France
  • Audrey Fel
    Ophtalmologie, Hôpital La Pitié Salpétrière Paris, Paris, France
  • Christine Fardeau
    Ophtalmologie, Hôpital La Pitié Salpétrière Paris, Paris, France
  • Phuc Lehoang
    Ophtalmologie, Hôpital La Pitié Salpétrière Paris, Paris, France
  • Bahram Bodaghi
    Ophtalmologie, Hôpital La Pitié Salpétrière Paris, Paris, France
  • Footnotes
    Commercial Relationships Céline Mebsout, None; Audrey Fel, None; Christine Fardeau, None; Phuc Lehoang, None; Bahram Bodaghi, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5785. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Céline Mebsout, Audrey Fel, Christine Fardeau, Phuc Lehoang, Bahram Bodaghi; Psoriatic uveitis : a potentially severe and sight-threatening entity?. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5785.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To describe the clinical characteristics and therapeutic management of psoriatic uveitis.

Methods: A retrospective study of patients with psoriatic uveitis referred to the Ophthalmology clinic of Pitié-Salpétrière Hospital.<br /> Clinical characteristics, therapy, complications and severity of uveitis were reviewed. Complications and the visual outcome have been evaluated in this group.

Results: Nine patients were finally included with a mean follow-up of 10.4 years. The mean age at presentation was 38.6 years. Among them, only 33.3% (3 of 9 patients) were HLA-B27 positive and 66.7% (6/9) had psoriatic arthritis. Uveitis was bilateral in 6 patients (66.7%). Posterior involvement was noted in 55.6% (5/9) of cases, (3 patients with vitritis, 3 with cystoid macular edema, 2 with papillitis and 1 with retinal vasculitis). Secondary glaucoma occurred in 2 patients (22.2%) with severe consequences. Twenty percent of affected eyes (3 of 15 eyes) developed legal blindness (visual acuity less than 20/400). The final visual acuity ranged from 20/20 to no light perception; with a mean visual acuity of 20/40. Uveitis was considered severe in 7 patients (77.8%). Three patients (33.3%) received long-term oral corticosteroids and 44.4% (4/9) required intravenous pulses of methylprednisolone. Methotrexate therapy was necessary in 6 patients (66.7%) and TNFα blockers were introduced in 5 patients (55.6%). Two patients needed other immunosuppressive agents (cyclosporine, azathioprine, mycophenolate mofetil, abatacept, anakinra and tocilizumab). Dexamethasone intravitreal implant was used in each eye of one patient for cystoid macular edema. Severe complications of therapy (skin carcinoma and severe infections) occurred in one patient.

Conclusions: In this case series, most of the patients had a severe psoriatic uveitis. Larger multicentre studies are needed in order to confirm these results and clearly identify this entity as a worrying condition, requiring an appropriate therapeutic strategy.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×